Akrotome Imaging, Inc.

We enable surgeons to achieve surgical cures for solid tumor cancers by "lighting up" tumors, showing where diseased tissue ends and healthy tissue begins.

  • Stage Prototype Ready
  • Industry Healthcare Services
  • Location Cleveland, OH, USA
  • Currency USD
  • Founded June 2008
  • Employees 4
  • Incorporation Type C-corp
  • Website akrotome.com

Company Summary

Akrotome is focused on the development of smart, fluorescent molecular probes for guided, solid-tumor cancer surgery. The FIRE(TM) family of probes enable surgeons to easily and precisely determine where diseased tissue ends and healthy tissue begins, facilitating the complete removal of all cancer tissue. Unlike other molecular probes, FIRE probes use minute (microdose) amounts of probe applied topically during the surgical procedure.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free